In this lecture, we will cover the evolution of modern-era multi-modality therapy for children with the most common extra-cranial solid tumor of childhood. Survival rates for children with high-risk neuroblastoma have doubled in the past two decades, but this progress has come with the use of lengthy, complex therapy. Our team will discuss the current state of therapy for these patients as well as the remaining challenges in the areas of surgery, radiation, and medical therapy for children with high-risk disease. We will also discuss new directions in therapy and new ways of thinking about neuroblastoma.
- Appreciate the advances made in the treatment of children with high risk neuroblastoma in recent years
- Identify the current challenges facing patients, families and providers during and after treatment
- Identify new opportunities to improve outcomes for children with this disease
This seminar focuses on oncology and was delivered at a virtual event titled, Advances in Multi-Disciplinary Care for Children with High-Risk Neuroblastoma, on March 19, 2021.
Additional CHOP Resources:
- Pediatric Proton Therapy Center
- Surgical Treatment for Neuroblastoma
- Solid Tumor Research
- Upcoming Healthcare Professionals Events
By starting this module, you agree to our Content Disclaimer and Terms of Service.
If this is your first time attempting to login to the new website with an existing account, you will first need to reset your password before logging in.Lost Your Password?
**By selecting “Yes”, you consent to receive information from CHOP. Once you have decided to receive such communications, you may later decide to stop receiving these communications. If you want to stop receiving these communications, you may send an email message to email@example.com.